May 14, 2018 | by City of Hope
City of Hope Physician-in-Chief Michael A. Caligiuri, M.D., has been named a 2018 Fellow of the American Association for Cancer Research’s AACR Academy.
Caligiuri, the Deana and Steve Campbell Physician-in-Chief distinguished Chair, is widely recognized as a health care visionary, and joined City of Hope in February 2018. He continues to serve as president of the AACR.
The mission of the AACR Academy is to recognize and honor distinguished scientists whose major scientific contributions have propelled significant innovation and progress against cancer, and to leverage the expertise of the global brain trust of fellows of the AACR Academy to advance the mission of the AACR to prevent and cure all cancers through research, education, communication and collaboration.
All fellows are nominated and elected through an annual peer-review process conducted by existing fellows of the AACR Academy and ratified by the AACR Executive Committee. This process involves a rigorous assessment of each candidate’s scientific achievements in cancer research and cancer-related sciences. Consideration of induction and election into the AACR Academy is restricted to individuals whose work has had a significant and enduring impact on the cancer research field.
“The 2018 fellows’ scientific expertise has dramatically transformed the cancer research landscape. Their collective efforts to improve cancer research and patient care are unparalleled, and have fundamentally altered the ways in which we study, prevent, diagnose and treat all cancers,” said Margaret Foti, Ph.D., M.D., chief executive officer of the AACR.
Caligiuri was one of just 12 fellows elected this year. He was chosen for his work in “elucidating the fundamental mechanisms of natural killer cell development and immune surveillance, and for his commitment to advancing cancer health disparities research and promoting the collection and use of clinical samples to guide screening, treatment and surveillance protocols,” according to the organization.
In his new role at City of Hope, Caligiuri is responsible for driving innovation in cancer care and delivery. Specifically, he is encouraging and developing new paradigms for translating state-of-the-art research into practice at City of Hope, the community and beyond. He is also responsible for optimizing the patient-care system to ensure the highest quality and safest patient experience.
Most recently, Caligiuri was director of The Ohio State University Comprehensive Cancer Center and CEO of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute in Columbus, Ohio.
As a physician-scientist, he is well-known for work in immunology that focuses on human natural killer cells and their modulation for the treatment of leukemia, myeloma and glioblastoma. More than 1,500 cancer patients have been treated on clinical protocols that have emanated from the Caligiuri laboratory.
The AACR will formally induct its 2018 class of elected fellows of the AACR Academy at the AACR Annual Meeting 2018, to be held in Chicago from April 14 to 18.